|
Platelets and the immune continuum.
Nat Rev Immunol. 2011 Abr; 11(4):264-74.
Semple JW, Italiano JE, Freedman J. |
|
Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting.
Platelets. 2011 Mar;
Huczek Z, Filipiak KJ, Kochman J, Michalak M, Roik M, Grabowski M, Opolski G. |
|
The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy.
Platelets. 2011 Mar; [Epub ahead of print] No abstract available. Mar
Nomura S, Fujita S, Ozasa R, Nakanishi T, Miyaji M, Mori S, Ito T, Ishii K. |
|
The effect of intravenous high-dose methylprednisolone on platelet reactivity assessed with multiple electrode aggregometry.
Thromb Haemost. 2011 Mar; 105(6) [Epub ahead of print] No abstract available. Mar
Robier C, Strohmeier L, Quehenberger F, Neubauer M, Stettin M, Rainer F. |
|
Platelets and the innate immune system: Mechanisms of bacterial-induced platelet activation.
J Thromb Haemost. 2011 Mar; doi: 10.1111/j.1538-7836.2011.04264.x. Epub ahead of print Mar
Cox D, Kerrigan SW, Watson SP. |
|
Computational approaches to studying thrombus development
Arterioscler Thromb Vasc Biol. 2011 Mar; 31(3):500-5.
Xu Z, Kamocka M, Alber M, Rosen ED. |
|
The anandamide effect on NO/cGMP pathway in human platelets
J Cell Biochem. 2011 Mar; 112(3):924-32.
Signorello MG, Giacobbe E, Passalacqua M, Leoncini G. |
|
The association between platelet activation and Fc?RIIa proteolysis
J Thromb Haemost. 2011 Feb; doi: 10.1111/j.1538-7836.2011.04239.x. Epub ahead of print Feb
Nazi I, Smith JW, Arnold DM, Horsewood P, Moore JC, Warkentin TE, Kelton JG. |
|
Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI Role of negatively charged phospholipids.
Atherosclerosis. 2011 Ene; Epub ahead of print Dic
Brodde MF, Korporaal SJ, Herminghaus G, Fobker M, Van Berkel TJ, Tietge UJ, Robeneck H, Van Eck M, Kehrel BE, Nofer JR. |
|
Regulation of serotonin transport in human platelets by tyrosine kinase syk
Cell Physiol Biochem. 2011 Ene; 27(2):139-48. Epub 2011 Feb 11
Pavanetto M, Zarpellon A, Borgo C, Donella-Deana A, Deana R. |
|
Increased nitric oxide production in platelets from severe chronic renal failure patients
Can J Physiol Pharmacol. 2011 Ene; 89(2):97-102.
Alves de Sá Siqueira M, Brunini TM, Rodrigues Pereira N, Martins MA, Bandeira Moss M, Santos SF, Lugon JR, Mendes-Ribeiro AC. |
|
Critical Role of Membrane Cholesterol in Exocytosis Revealed by Single Platelet Study.
ACS Chem Biol. 2010 Jul; Epub ahead of print Feb
Ge S, White JG, Haynes CL. |
|
Regulation of platelet {beta}3 integrins.
Haematologica. 2010 Jul; 95(7):1049-51. No abstract available. Feb
Bennett JS, Moore DT. |
|
STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE C-TERMINUS OF GAlphaQ IN COMPLEX WITH HUMAN THROMBOXANE A2 RECEPTOR PROVIDES EVIDENCE FOR CONSTITUTIVE ACTIVITY.
Biochemistry. 2010 Jun; Epub ahead of print Feb
Chillar A, Wu J, Cervantes V, Ruan KH. |
|
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
Eur J Cardiovasc Prev Rehabil. 2010 Jun; Epub ahead of print Feb
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; the EUROASPIRE Study Group. |
|
Progress in Platelet Medicine: Focus on Stent Thrombosis and Drug Resistance.
J Cardiothorac Vasc Anesth. 2010 Jun; Epub ahead of print Feb
Patel PA, Augoustides JG. |
|
Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2´-deoxyadenosine-3´,5´-bisphosphate ([(125)I]MRS2500).
Pharmacol Res. 2010 Jun; Epub ahead of print Feb
Ohlmann P, de Castro S, Brown GG Jr, Gachet C, Jacobson KA, Harden TK. |
|
The H(2)-receptor antagonist ranitidine interferes with clopidogrel-mediated P2Y(12) inhibition in platelets.
Pharmacol Res. 2010 Jun; Epub ahead of print Feb
Schäfer A, Flierl U, Pförtsch S, Seydelmann N, Micka J, Bauersachs J. |
|
Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
Cardiovasc Ther. 2010 Jun; 28(3):147-52.
Kojuri J, Mahmoody Y, Sabegh BZ, Jannati M, Mahboodi A, Khalili A. |
|
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
Eur J Med Res. 2010 May; 15(5):220-4.
Kenngott S, Olze R, Kollmer M, Bottheim H, Laner A, Holinski-Feder E, Gross M. |
